Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
International phase 3 trial in Ph+ ALL testing imatinib with two chemotherapy backbones
DRKS00017001Phase 3Active, not recruiting
- Sponsor
- University of Milano-Bicocca
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 22
01
Overview
Phase 3, randomised trial of imatinib in acute lymphoblastic leukemia (ALL) (3 arms), sponsored by University of Milano-Bicocca. Started May 2019; status: active, not recruiting.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on DRKS00017001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00017001.